In order to survey the quality of the marketed hypolipemic preparations in Taiwan area, a total of 38 samples (gemfibrozil, clofibrate, bezafibrate and simvastatin capsules and tablets) were collected from different counties and cities in Taiwan during January thru June 2007. Samples were analyzed by the methods as described in the USP XXVI. The items of analysis include the appearance, components identifcation and assay. All samples fulfilled the compendial requirement for Gemfibrozil, Clofibrate, Bezafibrate and Simvastatin. |